Screener
Sutro Biopharma STRO Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$38.53M-235% | -$38.48M+49.3% | -$46.76M+35.4% | -$56.86M-16.5% | -$11.5M+76.1% | ||
| $1.26M-33.6% | $1.28M-32.7% | $1.62M-13.1% | $1.9M+5.6% | $1.9M+6.1% | ||
| $2.01M-61.8% | $1.56M-71.8% | $1.66M-72.0% | $1.55M-76.3% | $5.26M-14.5% | ||
| -$38.29M+14.4% | -$42.26M+37.7% | -$26.44M+63.2% | -$38.19M+40.8% | -$44.72M— | ||
| $256K— | $0-100% | —— | $47K-91.5% | —— | ||
| —— | -$45.26M-178% | $18.7M-78.6% | $39.99M-72.9% | $2.58M+103% | ||
| —— | —— | —— | —— | —— | ||
| —— | $103.08M+156,074% | —— | $102K-90.0% | —— | ||
| -$19.35M+54.2% | $15.55M+118% | -$7.8M-150% | $0-100% | -$42.2M-265% | ||
| -$38.55M+13.8% | -$42.26M+37.8% | -$26.38M+63.2% | -$38.24M+41.2% | -$44.72M— |
FAQ
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$145.2M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $330.0K of capital expenditures, Sutro Biopharma's free cash flow was -$145.4M over the trailing twelve months, up 41.7% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
